Rab27A, Proteintech, 17817-1-AP

Our team performed a comprehensive review of the scientific literature to identify studies using antibodies against human Rab27A and Rab27B, followed by extraction and evaluation of available data according to pAbmAbs rating criteria.

YCharOS conducted a systematic head-to-head comparison of 14 commercially available antibodies against Rab27A and 7 against Rab27B across multiple applications

Antibodies were tested by WB using lysates (40 µg total protein) from U-87 MG WT cells and cells with siRNA-mediated knockdown (KD) of Rab27A or Rab27B. The same cell lines were used for IF testing. In addition, antibodies were evaluated by IP using HAP1 (Rab27A) or U-87 MG (Rab27B) cell lysates (1 mg), following YCharOS standard protocols (see reference).

In WB (1:1000 antibody dilution), 17817-1-AP detects a strong band at the expected size (~24 kDa) in WT U-87 MG lysate, with no corresponding band in lysates from Rab27A KD cells. In addition, two non-specific band of higher Mw are observed in both lysates.

In IP, the antibody (2 µg) enriches the Rab27A signal compared to the starting material (U-87 MG cell lysate), with a reduced signal observed in unbound fraction, indicating some, but incomplete depletion of the target from the cell lysate. Rab27A in the starting material, unbound fraction, and precipitate was detected by WB using the antibody 95394 from Cell Signaling Technology.

In IF, the antibody (1:150 antibody dilution) resulted in a strong signal from U-87 MG WT with some background observed in Rab27A KD cells.

We highly encourage other scientists to share their observations.